Title of article
Viral vectors for dendritic cell-based immunotherapy
Author/Authors
Lars Jenne، نويسنده , , Gerold Schuler، نويسنده , , Alexander Steinkasserer، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2001
Pages
6
From page
102
To page
107
Abstract
Transduction of dendritic cells (DCs) by viral vectors genetically engineered to express tumor-associated antigens (TAAs) or cytokines can produce a high level of transgene expression and is an attractive approach for DC-based immunotherapy. Ex vivo transduction allows the control of DC quality, antigen quantity and site of DC reinjection. This review evaluates the viral vectors currently being developed for use in DC-based immunotherapy.
Journal title
Trends in Immunology
Serial Year
2001
Journal title
Trends in Immunology
Record number
468192
Link To Document